IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 199
Titolo Data di pubblicazione Autore(i) File
THE ROLE OF THYMIDTYLATE SYNTHASE (TS) AND EXCISION REPAIR CROSS-COMPLEMENTING GROUP 1 (ERCC1) IMMUNOHISTOCHEMICAL EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) PATIENTS TREATED WITH PEMETREXED AND CARBOPLATIN 1-gen-2009 Zucali, Pa; Destro, A; Ceresoli, Gl; Gianoncelli, L; Lorenzi, E; De Vincenzo, F; Simonelli, M; Giordano, L; Roncalli, M; Santoro, A
The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin 1-gen-2009 Zucali, P; Destro, A; Ceresoli, Gl; Gianoncelli, L; Lorenzi, E; De Vincenzo, F; Simonelli, M; Giordano, L; Roncalli, M; Santoro, A
Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy and medical treatment in 60 patients 1-gen-2009 Incarbone, M; Ceresoli, Gl; Bottoni, E; Voulaz, E; Morenghi, E; Zucali, Pa; Gianoncelli, L; Testori, A; Ravasi, G; Scorsetti, M; Santoro, A; Alloisio, M
Early response evaluation in malignant pleural mesothelioma by analysis of serial FDG-PET scans 1-gen-2009 Ceresoli, Gl; Gianoncelli, L; Lorenzi, E; Giordano, L; Boucek, Ja; Zucali, Pa; Francis, Rj; Incarbone, M; Chiti, A; Santoro, A
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 1-gen-2009 Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A
Future developments in the management of malignant pleural mesothelioma 1-gen-2009 Zucali, Pa; De Vincenzo, F; Simonelli, M; Santoro, A
NGR-hTNF, a vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM): a phase II study 1-gen-2009 Gregorc, V.; Ceresoli, G. L.; Zucali, P. A.; De Braud, F. G.; Bajetta, E.; Santoro, A; Vigano, M. G.; Cappio F., Caligaris; Lambiase, A.; Bordignon, C.
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients 1-gen-2009 Cappuzzo, F.; Jänne, P. A.; Skokan, M.; Finocchiaro, G.; Rossi, E.; Ligorio, C.; Zucali, P. A.; Terracciano, L.; Toschi, L.; Roncalli, M.; Destro, A.; Incarbone, M.; Alloisio, M.; Santoro, A.; Varella-Garcia, M.
Second-line treatment for malignant pleural mesothelioma 1-gen-2010 Ceresoli, Giovanni Luca; Zucali, Paolo Andrea; Gianoncelli, Letizia; Lorenzi, Elena; Santoro, Armando
Expression and mutational status of c-kit in thymic epithelial tumors 1-gen-2010 Petrini, I.; Zucali, P.; Lee, H.; Pineda, M.; Meltzer, P.; Walter-Rodriguez, B.; Roncalli, M.; Santoro, A.; Wang, Y.; Giaccone, G.
Final results from ARQ 197-114: A phase 1b safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC) 1-gen-2010 Zucali, P; Santoro, A; Rodriguez-Lope, C; Simonelli, M; Camacho, Lh; Senzer, Nn; Bolondi, L; Lamar, M; Abbadessa, G; Schwartz, Be
Insulin-Like Growth Factor-1 Receptor and Phosphorylated AKT-Serine 473 Expression in 132 Resected Thymomas and Thymic Carcinomas 1-gen-2010 Zucali, PAOLO ANDREA; Petrini, I; Lorenzi, E; Merino, M; Cao, L; Di Tommaso, L; Lee, H S; Incarbone, M; Walter, B A; Simonelli, M; Roncalli, M; Santoro, A; Giaccone, G; RI Lee, H S
PHASE I AND PHARMACODYNAMIC STUDY OF NGR-HTNF ADMINISTERED AT HIGH DOSES IN REFRACTORY PATIENTS WITH SOLID TUMORS 1-gen-2010 Zucali, Pa; Santoro, A; Simonelli, M; De Vincenzo, F; Lorenzi, E; Rimassa, L; Balzarini, L; Quagliuolo, V; Lambiase, A; Bordignon, C
Phase I study of NGR-hTNF administered at high doses in refractory patients with solid tumors 1-gen-2010 Simonelli, M; Santoro, A; Zucali, Pa; Rimassa, L; De Vincenzo, F; Pressiani, T; Tronconi, Mc; Carnaghi, C; Lambiase, A; Bordignon, C
Association of Polymorphisms in AKT1 and EGFR with Clinical Outcome and Toxicity in Non-Small Cell Lung Cancer Patients Treated with Gefitinib 1-gen-2010 Giovannetti, E; Zucali, PAOLO ANDREA; Peters, G J; Cortesi, F; D'Incecco, A; Smit, Ef.; Falcone, A; Burgers, J A; Santoro, A; Danesi, R; Giaccone, G; Tibaldi, C; Ri, G E
Phase II Study of Asparagine-Glycine-Arginine-Human Tumor Necrosis Factor alpha, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma 1-gen-2010 Gregorc, V; Zucali, PAOLO ANDREA; Santoro, A; Ceresoli, G L; Citterio, G; De Pas T, M.; Zilembo, N; De Vincenzo, F; Simonelli, M; Rossoni, G; Spreafico, A; Vigano, M G; Fontana, F; De Braud, F G; Bajetta, E; Caligaris-Cappio, F; Bruzzi, P; Lambiase, A; Bordignon, C
New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma 1-gen-2010 Zucali, P. A.; Giovannetti, E.; Assaraf, Y. G.; Ceresoli, G. L.; Peters, G. J.; Santoro, A
The Role of Pemetrexed in the Pharmacotherapy of Malignant Pleural Mesothelioma 1-gen-2010 Zucali, P.; De Vincenzo, F.; Simonelli, M.; Lorenzi, E.; Perrino, M.; Santoro, A.
Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study 1-gen-2010 De Vincenzo, F; Zucali, P; Ceresoli, G; Gianoncelli, L; Lorenzi, E; Simonelli, M; Ripa, C; Giordano, L; Santoro, A
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy 1-gen-2010 Prognostic Factors Study Group, International; Simonelli, M; Zucali, P; Lorch, Anja; Beyer, Jörg; Bascoul-Mollevi, Caroline; Kramar, Andrew; H Einhorn, Lawrence; Necchi, Andrea; Massard, Christophe; De Giorgi, Ugo; Fléchon, Aude; A Margolin, Kim; Lotz, Jean-Pierre; Ramon Germa Lluch, Jose; Powles, Thomas; K Kollmannsberger, Christian
Mostrati risultati da 41 a 60 di 199
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile